What GVS does

GVS S.p.A. is an Italian-headquartered, publicly listed (Borsa Italiana MTA, since June 2020) developer and manufacturer of advanced filtration products founded in 1979. The company designs and produces microporous membranes, track-etched membranes, and specialty filter media under five business divisions: MedTech (drug delivery, blood treatment, respiratory/anesthesia), Transfusion Medicine (end-to-end blood management from collection to transfusion), Life Sciences (laboratory and bioprocessing membranes), Safety (respiratory protection including PAPR/SAR from the 2021 RPB Group acquisition), and Energy & Mobility (automotive, EV battery cooling, powertrain filtration). Notable technical assets include the patented SQ40 High Flow Blood Filter with 161 cm² surface area and hydrophobic glass microfiber media achieving 99.999993% BFE / 99.9995% VFE. GVS operates 19 manufacturing plants across 8 countries (Italy, UK, Brazil, USA, China, Mexico, Romania, Puerto Rico) and 29 commercial offices globally, with products cataloged across 561+ SKUs.

GVS generates revenue primarily through hardware sales of filtration products across its five divisions, with two principal revenue streams: (1) standard filtration products and technologies sold via direct regional sales teams and the corporate website catalog, and (2) customized OEM products developed for medical device manufacturers and industrial clients with integrated design and regulatory compliance support. The go-to-market combines direct-to-consumer-style regional sales (organized by geography including North America, EMEA, Brazil, South Korea, Central America, China, South America, Japan, and SEA+AU), event-driven demand generation at industry trade shows (ISBT, AfSBT), and OEM-embedded partnerships. Pricing is quote-based and not publicly disclosed, with product catalogs available for download and specifications distributed via the corporate website. Customers include hospitals, blood centers, diagnostic clients, OEM medical device partners, life sciences laboratories, and industrial/automotive end users. 2024 disclosed financials were €429M revenue, €104M EBITDA, and €48M net profit, with 2.1x Net Debt/EBITDA.

Name

GVS

Legal name

GVS S.p.A.

Website

https://gvs.com

Company type

Public

Founded year

1979

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

GVS is an Italian public filtration technology company that designs and manufactures microporous and track-etched membranes, blood filters, and respiratory protection devices across five divisions (MedTech, Transfusion Medicine, Life Sciences, Safety, Energy & Mobility), serving hospitals, blood centers, OEMs, and industrial clients from 19 plants in 8 countries.

Ownership category

akta.pro rank

Product category

Filtration Products and Technologies

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Separation & Filtration Equipment (Filters, Centrifuges, Membranes) (IMAHAEAB)

akta.pro secondary industries

Dust Collection & Air Filtration Equipment (Industrial) (IMAHALAF), Air Quality & Filtration Equipment (IAQ) (IMAHAKAI)

Keywords

• Filtration products
• Microporous membranes
• Medical filtration devices
• Respiratory protection equipment
• Automotive filtration solutions

Headquarters

HQ city

Zola Predosa

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Filtration Products and Technologies: GVS generates revenue through the manufacture and sale of a wide range of filters and filtration technologies. The company produces filters for healthcare (drug delivery, blood treatment, respiratory/anesthesia systems), transfusion medicine, life sciences (laboratory and membranes), safety (respiratory protection devices), and energy & mobility (automotive and industrial filtration). Revenue is primarily from product sales across five divisions.
2. OEM Custom Products: GVS develops and manufactures customized OEM filter products for medical device manufacturers and industrial clients, providing integrated design approaches with regulatory compliance for hospital and diagnostic clients.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

GVS develops and manufactures proprietary filtration products and technologies — including microporous and track-etched membranes, hydrophobic glass microfiber media, blood and respiratory filters, and OEM-customized filter components — organized into five divisions serving medical, transfusion, life sciences, safety, and energy/mobility customers from 19 manufacturing plants worldwide. Revenue is generated primarily through sale of these manufactured filtration products to hospitals, diagnostic labs, blood centers, OEM medical device partners, laboratories, industrial safety users, and automotive/EV manufacturers.

Differentiator

Problem solved

Functional benefit

Products and services

• MedTech Filtration Products Filtration components and solutions for the medical sector covering drug delivery devices, blood treatment, extracorporeal circuits, and respiratory and anesthesia systems; supplied to hospitals, diagnostic clients, and OEM medical device manufacturers.
• Transfusion Medicine Products End-to-end blood management filtration and bag systems — including blood collection, processing, filtration, storage, and transfusion solutions such as blood bag systems, pooling sets, dockable systems, and blood filters — supplied to hospitals, blood centers, and OEM partners globally.
• Life Sciences Filtration Products Microporous and track-etched membranes, disc and sheet membranes, and laboratory filtration consumables for chromatography, microbiology, cell culture, proteomics, sample preparation, bioprocessing, and quality controls — supplied to laboratories, research centers, and life sciences customers.
• Safety Respiratory Protection Products High-performance respiratory protection and personal safety devices for industrial, institutional, and professional use, including Elipse respirators, Segre FFP3/N99 masks, Bacticell HVAC filters, HEPA adapters, and SAR/PAPR systems from the RPB Group acquisition.
• Energy & Mobility Filtration Products High-performance filtration solutions for automotive and industrial mobility applications, covering combustion engines, hybrid vehicles, EV and battery systems (including battery cooling), powertrain, drivetrain, fuel systems, oil & transmission, safety electronics, and Viral Shield Cabin Air.
• OEM Custom Filter Solutions Customized OEM filtration products developed for medical device manufacturers and industrial clients, delivered through an integrated design approach with regulatory compliance and embedded into customers' devices and systems.

Quantifiable outcome

• BFE (Bacterial Filtration Efficiency) of 99.999993% and VFE (Viral Filtration Efficiency) of 99.9995% for Gas/Vent Filters
• +3 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• RPB GroupcoreStrategic or Co-development Partner · 1 September 2021In September 2021, GVS completed the product range in the field of positive pressure respirators through the acquisition of RPB Group, a US-based manufacturer specialized in the design and production of respiratory protection devices including supplied-air respirators (SAR) and powered air-purifying respirators (PAPR). This strategic acquisition expanded GVS's Safety division capabilities significantly.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/gvscom
• Facebookfacebook.com/gvsfiltertechnology
• LinkedInlinkedin.com/company/gvs-filter-technology

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GVS